Delivery Order SPE2DX15D3017-SPE2DX23F0PHF
Award Date
9/19/23
Potential Completion Date
9/20/23
Potential Value
$7.1K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $24,701.59, is for the supply of Olumiant 4 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of October 25, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,292.85 firm fixed price contract is for the supply of the medication Olumiant 2 mg tablet. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,908.02 firm fixed-price delivery order is for the supply of Olumiant 2 mg tablets, a medication used to treat certain autoimmune conditions. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $82,443.07 for the delivery of Olumiant 4 mg tablets. The contract has a period of performance through September 25, 2024 and is structured as a firm-fixed-price arrangement. This delivery order is placed against an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling...
This is a delivery order under a federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $18,864.14 firm-fixed-price order is for the prescription medication Olumiant 2 mg tablets. The award has an ultimate completion date of August 7, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a DLA Troop Support Medical IDC valued up to $999,999,999 through December 2025 to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OLUMIANT 2 MG TABLET 30S. The contract has a ceiling value of $30,262.56 and is a firm fixed-price delivery order. The ultimate completion date is May 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract is valued at $4,708.96 and runs through August 28, 2024. AmerisourceBergen, as a major pharmaceutical distributor, provides a wide range of prescription medications, medical supplies, and equipment to support various government agencies and healthcare programs, including military treatment facilities...
This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS4PN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $41,565.55 and is a delivery order for the supply of the medication Olumiant 4 mg tablet in 30-count packaging. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,085.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,272.35 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...